These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 35174673)

  • 21. Effect of gastrointestinal manifestations on quality of life in 87 consecutive patients with systemic sclerosis.
    Omair MA; Lee P
    J Rheumatol; 2012 May; 39(5):992-6. PubMed ID: 22467930
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Association of gastrointestinal involvement and depressive symptoms in patients with systemic sclerosis.
    Bodukam V; Hays RD; Maranian P; Furst DE; Seibold JR; Impens A; Mayes MD; Clements PJ; Khanna D
    Rheumatology (Oxford); 2011 Feb; 50(2):330-4. PubMed ID: 20884655
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Validation of the UCLA Scleroderma Clinica Trial Gastrointestinal Tract Instrument version 2.0 for systemic sclerosis.
    Baron M; Hudson M; Steele R; Lo E;
    J Rheumatol; 2011 Sep; 38(9):1925-30. PubMed ID: 21724704
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Symptoms related to gastrointestinal tract involvement and low muscularity in systemic sclerosis.
    Rosato E; Gigante A; Pellicano C; Villa A; Iannazzo F; Alunni Fegatelli D; Muscaritoli M
    Clin Rheumatol; 2022 Jun; 41(6):1687-1696. PubMed ID: 35149929
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The microbiome and systemic sclerosis: A review of current evidence.
    Tan TC; Noviani M; Leung YY; Low AHL
    Best Pract Res Clin Rheumatol; 2021 Sep; 35(3):101687. PubMed ID: 33849778
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prevalence and predictors of small intestinal bacterial overgrowth in systemic sclerosis patients with gastrointestinal symptoms.
    Tauber M; Avouac J; Benahmed A; Barbot L; Coustet B; Kahan A; Allanore Y
    Clin Exp Rheumatol; 2014; 32(6 Suppl 86):S-82-7. PubMed ID: 25372792
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Microbial and metabolic multi-omic correlations in systemic sclerosis patients.
    Bellocchi C; Fernández-Ochoa Á; Montanelli G; Vigone B; Santaniello A; Milani C; Quirantes-Piné R; Borrás-Linares I; Ventura M; Segura-Carrettero A; Alarcón-Riquelme ME; Beretta L
    Ann N Y Acad Sci; 2018 Jun; 1421(1):97-109. PubMed ID: 29749635
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Severe gastrointestinal disease in very early systemic sclerosis is associated with early mortality.
    Richard N; Hudson M; Wang M; Gyger G; Proudman S; Stevens W; Nikpour M; ; ; Baron M
    Rheumatology (Oxford); 2019 Apr; 58(4):636-644. PubMed ID: 30517716
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The Gut Microbiome in Patients With Chronic Pancreatitis Is Characterized by Significant Dysbiosis and Overgrowth by Opportunistic Pathogens.
    Frost F; Weiss FU; Sendler M; Kacprowski T; Rühlemann M; Bang C; Franke A; Völker U; Völzke H; Lamprecht G; Mayerle J; Aghdassi AA; Homuth G; Lerch MM
    Clin Transl Gastroenterol; 2020 Sep; 11(9):e00232. PubMed ID: 33094959
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Gastrointestinal tract microbiota modifications in systemic sclerosis.
    Volkmann ER; Hoffmann-Vold AM
    Eur J Rheumatol; 2020 Oct; 7(Suppl 3):S228-S236. PubMed ID: 31922474
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Gastrointestinal manifestations associated with systemic sclerosis: results from the nationwide inpatient sample.
    Alastal Y; Hammad TA; Renno A; Khalil B; Pierre J; Kwaah B; Khuder SA; Nawras A
    Ann Gastroenterol; 2017; 30(5):498-503. PubMed ID: 28845104
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The gut microbiome of COVID-19 recovered patients returns to uninfected status in a minority-dominated United States cohort.
    Newsome RC; Gauthier J; Hernandez MC; Abraham GE; Robinson TO; Williams HB; Sloan M; Owings A; Laird H; Christian T; Pride Y; Wilson KJ; Hasan M; Parker A; Senitko M; Glover SC; Gharaibeh RZ; Jobin C
    Gut Microbes; 2021; 13(1):1-15. PubMed ID: 34100340
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Anti-RNPC-3 (U11/U12) Antibodies in Systemic Sclerosis in Patients With Moderate-to-Severe Gastrointestinal Dysmotility.
    McMahan ZH; Domsic RT; Zhu L; Medsger TA; Casciola-Rosen L; Shah AA
    Arthritis Care Res (Hoboken); 2019 Sep; 71(9):1164-1170. PubMed ID: 30242973
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Validation of Serbian version of UCLA Scleroderma Clinical Trial Consortium Gastrointestinal Tract Instrument in 104 patients with systemic sclerosis.
    Zekovic A; Damjanov N
    Rheumatol Int; 2017 May; 37(5):735-741. PubMed ID: 28271157
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Mycophenolate mofetil for systemic sclerosis: drug exposure exhibits considerable inter-individual variation-a prospective, observational study.
    Andréasson K; Neringer K; Wuttge DM; Henrohn D; Marsal J; Hesselstrand R
    Arthritis Res Ther; 2020 Oct; 22(1):230. PubMed ID: 33023643
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Reliability and validity of the University of California, Los Angeles Scleroderma Clinical Trial Consortium Gastrointestinal Tract Instrument.
    Khanna D; Hays RD; Maranian P; Seibold JR; Impens A; Mayes MD; Clements PJ; Getzug T; Fathi N; Bechtel A; Furst DE
    Arthritis Rheum; 2009 Sep; 61(9):1257-63. PubMed ID: 19714600
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The Relationship Between Autonomic Dysfunction of the Gastrointestinal Tract and Emotional Distress in Patients With Systemic Sclerosis.
    DiRenzo D; Russell J; Bingham CO; McMahan Z
    J Clin Rheumatol; 2021 Jan; 27(1):11-17. PubMed ID: 31524844
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Disease frequency, patient characteristics, comorbidity outcomes and immunosuppressive therapy in systemic sclerosis and systemic sclerosis-associated interstitial lung disease: a US cohort study.
    Li Q; Wallace L; Patnaik P; Alves M; Gahlemann M; Kohlbrenner V; Raabe C; Wang JR; Garry EM
    Rheumatology (Oxford); 2021 Apr; 60(4):1915-1925. PubMed ID: 33155024
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Dysbiosis of gut microbiota in patients with neuromyelitis optica spectrum disorders: A cross sectional study.
    Shi Z; Qiu Y; Wang J; Fang Y; Zhang Y; Chen H; Du Q; Zhao Z; Yan C; Yang M; Zhou H
    J Neuroimmunol; 2020 Feb; 339():577126. PubMed ID: 31841737
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Incidence, prevalence and long-term progression of Goh algorithm rated interstitial lung disease in systemic sclerosis in two independent cohorts in flanders: A retrospective cohort study.
    Vandecasteele E; Melsens K; Vanhaecke A; Blockmans D; Bonroy C; Carton C; Deschepper E; De Keyser F; Houssiau F; Piette Y; Vanthuyne M; Verbeke K; Westhovens R; Wuyts WA; De Langhe E; Brusselle G; Smith V
    Semin Arthritis Rheum; 2021 Oct; 51(5):969-976. PubMed ID: 34403812
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.